Long-term regulation of genetically modified primary hematopoietic cells in dogs

We report long-term results from a large animal model of in vivo selection. Nine years ago, we transplanted two dogs (E900 and E958) with autologous marrow CD34+ cells that had been transduced with a gammaretrovirus vector encoding a conditionally activatable derivative of the thrombopoietin recepto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Okazuka, Kiyoshi (VerfasserIn) , Beard, Brian C (VerfasserIn) , Emery, David W (VerfasserIn) , Schwarzwälder, Kerstin (VerfasserIn) , Spector, Michele R (VerfasserIn) , Sale, George E (VerfasserIn) , Kalle, Christof von (VerfasserIn) , Kiem, Hans-Peter (VerfasserIn) , Blau, C. Anthony (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2011
In: Molecular therapy
Year: 2011, Jahrgang: 19, Heft: 7, Pages: 1287-1294
ISSN:1525-0024
DOI:10.1038/mt.2011.8
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/mt.2011.8
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1525001616324959
Volltext
Verfasserangaben:Kiyoshi Okazuka, Brian C Beard, David W Emery, Kerstin Schwarzwaelder, Michele R Spector, George E Sale, Christof von Kalle, Hans-Peter Kiem and C Anthony Blau

MARC

LEADER 00000caa a2200000 c 4500
001 1818780895
003 DE-627
005 20230710111553.0
007 cr uuu---uuuuu
008 221012s2011 xx |||||o 00| ||eng c
024 7 |a 10.1038/mt.2011.8  |2 doi 
035 |a (DE-627)1818780895 
035 |a (DE-599)KXP1818780895 
035 |a (OCoLC)1389769826 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Okazuka, Kiyoshi  |e VerfasserIn  |0 (DE-588)1270062166  |0 (DE-627)1818781727  |4 aut 
245 1 0 |a Long-term regulation of genetically modified primary hematopoietic cells in dogs  |c Kiyoshi Okazuka, Brian C Beard, David W Emery, Kerstin Schwarzwaelder, Michele R Spector, George E Sale, Christof von Kalle, Hans-Peter Kiem and C Anthony Blau 
264 1 |c 2011 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.10.2022 
500 |a First published online: 14 December 2016 
520 |a We report long-term results from a large animal model of in vivo selection. Nine years ago, we transplanted two dogs (E900 and E958) with autologous marrow CD34+ cells that had been transduced with a gammaretrovirus vector encoding a conditionally activatable derivative of the thrombopoietin receptor. Receptor activation through administration of a chemical inducer of dimerization (CID) (AP20187 or AP1903) confers a growth advantage. We previously reported responses to two 30-day intravenous (i.v.) courses of AP20187 administered within the first 8 months post-transplantation. We now report responses to 5-day subcutaneous (s.c.) courses of AP20187 or AP1903 at months 14, 90, and 93 (E900), or month 18 (E958), after transplantation. Long-term monitoring showed no rise in transduced cells in the absence of drug. Retroviral insertion site analysis showed that 4 of 6 (E958) and 5 of 12 (E900) transduced hematopoietic cell clones persisted lifelong. Both dogs were euthanized for reasons unrelated to the gene therapy treatment at 8 years 11 months (E958) and 11 years 1 month (E900) of age. Three clones from E900 remained detectable in each of two secondary recipients, one of which was treated with, and responded to, AP1903. Our results demonstrate the feasibility of safely regulating genetically engineered hematopoietic cells over many years. 
700 1 |a Beard, Brian C  |e VerfasserIn  |4 aut 
700 1 |a Emery, David W  |e VerfasserIn  |4 aut 
700 1 |a Schwarzwälder, Kerstin  |e VerfasserIn  |4 aut 
700 1 |a Spector, Michele R  |e VerfasserIn  |4 aut 
700 1 |a Sale, George E  |e VerfasserIn  |4 aut 
700 1 |a Kalle, Christof von  |d 1962-  |e VerfasserIn  |0 (DE-588)1036481115  |0 (DE-627)75107926X  |0 (DE-576)168957396  |4 aut 
700 1 |a Kiem, Hans-Peter  |e VerfasserIn  |4 aut 
700 1 |a Blau, C. Anthony  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 19(2011), 7 vom: Juli, Seite 1287-1294  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a Long-term regulation of genetically modified primary hematopoietic cells in dogs 
773 1 8 |g volume:19  |g year:2011  |g number:7  |g month:07  |g pages:1287-1294  |g extent:8  |a Long-term regulation of genetically modified primary hematopoietic cells in dogs 
856 4 0 |u https://doi.org/10.1038/mt.2011.8  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1525001616324959  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221012 
993 |a Article 
994 |a 2011 
998 |g 1036481115  |a Kalle, Christof von  |m 1036481115:Kalle, Christof von  |d 910000  |e 910000PK1036481115  |k 0/910000/  |p 7 
999 |a KXP-PPN1818780895  |e 4196426182 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"language":["eng"],"part":{"year":"2011","text":"19(2011), 7 vom: Juli, Seite 1287-1294","volume":"19","extent":"8","pages":"1287-1294","issue":"7"},"recId":"320415198","title":[{"title_sort":"Molecular therapy","title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy"}],"origin":[{"publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla.","dateIssuedKey":"2000","dateIssuedDisp":"2000-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.05.2020"],"corporate":[{"display":"American Society of Gene Therapy","role":"isb"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Long-term regulation of genetically modified primary hematopoietic cells in dogsMolecular therapy","id":{"issn":["1525-0024"],"eki":["320415198"],"zdb":["2001818-6"]},"pubHistory":["1.2000 -"]}],"id":{"doi":["10.1038/mt.2011.8"],"eki":["1818780895"]},"physDesc":[{"extent":"8 S."}],"note":["Gesehen am 12.10.2022","First published online: 14 December 2016"],"name":{"displayForm":["Kiyoshi Okazuka, Brian C Beard, David W Emery, Kerstin Schwarzwaelder, Michele R Spector, George E Sale, Christof von Kalle, Hans-Peter Kiem and C Anthony Blau"]},"person":[{"display":"Okazuka, Kiyoshi","given":"Kiyoshi","family":"Okazuka","role":"aut"},{"family":"Beard","display":"Beard, Brian C","given":"Brian C","role":"aut"},{"role":"aut","display":"Emery, David W","given":"David W","family":"Emery"},{"role":"aut","given":"Kerstin","display":"Schwarzwälder, Kerstin","family":"Schwarzwälder"},{"role":"aut","family":"Spector","given":"Michele R","display":"Spector, Michele R"},{"family":"Sale","given":"George E","display":"Sale, George E","role":"aut"},{"given":"Christof von","display":"Kalle, Christof von","family":"Kalle","role":"aut"},{"family":"Kiem","given":"Hans-Peter","display":"Kiem, Hans-Peter","role":"aut"},{"display":"Blau, C. Anthony","given":"C. Anthony","family":"Blau","role":"aut"}],"recId":"1818780895","title":[{"title_sort":"Long-term regulation of genetically modified primary hematopoietic cells in dogs","title":"Long-term regulation of genetically modified primary hematopoietic cells in dogs"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"language":["eng"]} 
SRT |a OKAZUKAKIYLONGTERMRE2011